Emerald Bioventures, LLC

13D and 13G Filings

13D/G filings
13D on 1 security
CIK
0002020620
All SEC filings
View on sec.gov
Issuer % of Class Filed
Galera Therapeutics, Inc. 13D/A Amendment 1
GRTX · 36338D108
30.2% 5/29/2026
Event 5/15/2026
Galera Therapeutics, Inc. 13D
GRTX · 36338D108
26.5% 4/27/2026
Event 4/7/2026

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.